Drug
Iloprost clinical trials
Also written Ventavis, Ilomedin and ZK 36374.
- studies test it
- 61
- open now
- 3
- in phase 3
- 15
- first study started
- 1995
Keep track of what changes. Save the Iloprost studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
61 studies that test it; most in 2006 (9)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 2000 | 1 |
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 9 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 8
- Phase 2
- 26
- Phase 3
- 15
- Phase 4
- 8
- No phase
- 9
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 47
Actelion (8) · Pär Johansson (4) · Yonsei University (3) · Bayer (3) · University of Oklahoma (2) · National Cancer Institute (NCI) (2) · Shanghai Jiao Tong University School of Medicine (2) · Thrombologic ApS (2)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Iloprost is read from its arms, and is right about nine times in ten.
Testing it · 61
- Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial HypertensionRecruitingPhase 4University of Sao Paulo General HospitalNCT07713914Written as Prostacyclin Pathway Agent
- Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell DiseaseNot yet recruitingPhase 3University Hospital, RouenNCT07498309Written as Iloprost
- Infusion of Prostacyclin vs Placebo for 72-hours in Mechanically Ventilated Patients With Acute Respiratory FailureRecruitingPhase 2Pär JohanssonNCT06319274Written as Iloprost
- Iloprost Power 15 in Pulmonary Arterial HypertensionCompletedPhase 3ActelionNCT00709956Written as iloprost (5 µg)
- The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial HypertensionTerminatedPhase 3ActelionNCT00302211Written as Inhaled Iloprost (5 μg)
- Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric OxideTerminatedPhase 4Duke UniversityNCT02170519Written as Inhaled Iloprost
- ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)CompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT03788837Written as ILOPROST
- Oral Iloprost for the Prevention of Lung Cancer In Former SmokersWithdrawnPhase 2National Cancer Institute (NCI)NCT05411107Written as Iloprost
- Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ FailureCompletedPhase 2Pär JohanssonNCT03903939Written as Iloprost
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ FailureCompletedPhase 2/3Jakob Stensballe, MD, PhDNCT04123444Written as Iloprost
- Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in COVID-19 Patients With Respiratory FailureCompletedPhase 2Pär JohanssonNCT04420741Written as Iloprost
- Outpatient Vasodilator Assessment Using Iloprost in Pulmonary HypertensionTerminatedPhase 4Duke UniversityNCT03044314Written as Iloprost and nitric oxide administration
- Iloprost in Gas Exchange/Pulm Mechanics in Chronic Obstructive Pulmonary Disease (COPD)CompletedNot applicableUniversity of OklahomaNCT00561223Written as iloprost Inhalation
- Iloprost in Preventing Lung Cancer in Former SmokersCompletedPhase 1National Cancer Institute (NCI)NCT02237183Written as Iloprost
- A Clinical Trial Investigating Iloprost as Medication to Improve Bone Healing in Patients With Proximal Humeral FractureStatus unknownPhase 1/2Charite University, Berlin, GermanyNCT04543682Written as 0.125 ng/kg/min Iloprost
- Inhaled Iloprost for Suspected COVID-19 Respiratory FailureCompletedPhase 2Hamad Medical CorporationNCT04445246Written as Inhaled ILOPROST
- Iloprost in Acute Respiratory Distress SyndromeCompletedPhase 3University Hospital TuebingenNCT03111212Written as Iloprost
- Endothelial Dysfunction in Resuscitated Cardiac ArrestCompletedPhase 2Pär JohanssonNCT02685618Written as Iloprost
- Effect of Intraoperative Iloprost Inhalant on Hemodynamic Stability in Patients Undergoing Off-pump Coronary Artery Bypass Graft SurgeryStatus unknownNot applicableYonsei UniversityNCT04598191Written as Iloprost
- Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseaseCompletedPhase 2University of Colorado, DenverNCT00084409Written as iloprost
Codes
What other systems call Iloprost · ClinicalTrials.gg INT008525
- MeSH (NLM) D016285IloprostConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) JED5K35YGLILOPROSTConfirmed FDA, NLM, Wikidata
- RxNorm 40138Confirmed FDA, Wikidata
- Wikidata Q20817139iloprostConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48397IloprostOne source FDA
- DrugBank DB01088One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016285 | Iloprost | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | JED5K35YGL | ILOPROST | Confirmed FDA, NLM, Wikidata |
| RxNorm | 40138 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20817139 | iloprost | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48397 | Iloprost | One source FDA |
| DrugBank | DB01088 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.